Skip to content

Venom 0406860125Recalls & reported problems

Stryker Corporation · RF Cannula, CVD · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613327118605), received between May 26, 2021 and Oct 15, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Biocompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Biocompatibility1
  • Unintended Power Up1

Patient problems

  • Local Reaction1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 15, 2025Unintended Power Up; Unintended Power Up

    IT WAS REPORTED THAT PRIOR A PROCEDURE THE E-SEP SAFEAIR PENCIL WAS FOUND TO BE FAULT. IT WAS ACTIVATING ON ITS OWN. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITHOUT A DELAY; NO ADVERSE CONSEQUENCES OR INJURY WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23300825 ↗
  • MalfunctionMay 26, 2021Biocompatibility; Biocompatibility

    IT WAS REPORTED THAT A COUPLE OF DAYS FOLLOWING AN RF ABLATION PROCEDURE THE PATIENT PRESENTED WITH PAIN AT THE SITE OF ABLATION DURING A TELEMEDICINE APPOINTMENT. UPON REFERRAL TO A DERMATOLOGIST AN ALLERGIC REACTION WAS DIAGNOSED AND SILVER SULFADIAZINE CREAM WAS PRESCRIBED. THE SITE HAS CONTINUED TO HEAL AND NO FURTHER ADVERSE CONSEQUENCES HAVE BEEN REPORTED.

    Patient problems: Local Reaction

    MAUDE report 11886308 ↗

Other PROBE, RADIOFREQUENCY LESION devices

All PROBE, RADIOFREQUENCY LESION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page